FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034001674> ?p ?o ?g. }

• W2034001674 endingPage "883" @default.
• W2034001674 startingPage "878" @default.
• W2034001674 abstract "Haematoporphyrin derivatives (HPDs) are potent sensitizers in photodynamic therapy (PDT), associated with prolonged skin photosensitivity. 5-Aminolaevulinic acid (5-ALA), a natural precusor of haem, is converted intracellularly into the photosensitive agent protoporphyrin IX (PPIX), causing direct cytotoxicity after laser light irradiation but limited skin photosensitivity over 1-2 days and higher tumour selectivity. Unfortunately, the use of 5-ALA in PDT has been shown to cause only superficial tissue necrosis. Therefore, a combination of HPD and 5-ALA could be of great clinical value in the treatment of tumours if a synergistic effect of both sensitizers on tumour cell necrosis with less skin photosensitivity could be demonstrated. Human colon adenocarcinoma cells (HT-29) were cultured with either HPD or 5-ALA alone, simultaneously for 24 h with 5-ALA and HPD or in succession with 5-ALA (18 h) followed by HPD (6 h at different concentrations. Intracellular PPIX concentrations were determined by high-performance thin-layer chromatography. Furthermore, PDT was performed with an incoherent light source (lambda = 580-740 nm) using a light dose of 30 J cm(-2) and an output power of 40 mW cm(-2). The intracellular PPIX concentration correlated well with 5-ALA drug dose and incubation time and was highest after single 5-ALA sensitization. In the presence of HPD, either simultaneously or sequentially, PPIX decreased significantly. The PDT effect after simultaneous incubation with both sensitizers for 24 h was not superior to incubation with HPD alone. If 5-ALA incubation (18 h) was followed by HPD (6 h) cytotoxicity after PDT was higher than with either single drug. 5-ALA (80 microg ml(-1)) led to a decrease in tumour cell viability by 40%. A similar effect could be observed when 5-ALA and HPD were sequentially combined allowing for a reduction of the 5-ALA dose from 80 microg ml(-1) in the absence of HPD to 60 microg ml(-1) and 5 microg ml(-1) together with 0.5 microg ml(-1) and 2 microg ml(-1) HPD respectively. We speculate that the enhanced PDT effect after the combined administration of 5-ALA and HPD to cultures of colon carcinoma cells should be even more impressive in the tumour in vivo, since HPD primarily targets the tumour microvasculature and secondarily tumour cells." @default.
• W2034001674 created "2016-06-24" @default.
• W2034001674 creator A5002640669 @default.
• W2034001674 creator A5015252905 @default.
• W2034001674 creator A5036548349 @default.
• W2034001674 creator A5048013654 @default.
• W2034001674 creator A5051457514 @default.
• W2034001674 creator A5062243111 @default.
• W2034001674 creator A5073877780 @default.
• W2034001674 creator A5074748428 @default.
• W2034001674 creator A5085788744 @default.
• W2034001674 creator A5046807325 @default.
• W2034001674 date "1997-10-01" @default.
• W2034001674 modified "2023-10-18" @default.
• W2034001674 title "Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells" @default.
• W2034001674 cites W1575245735 @default.
• W2034001674 cites W1964219512 @default.
• W2034001674 cites W1965514362 @default.
• W2034001674 cites W1985441660 @default.
• W2034001674 cites W1988652490 @default.
• W2034001674 cites W1993725955 @default.
• W2034001674 cites W2042036666 @default.
• W2034001674 cites W2044803197 @default.
• W2034001674 cites W2069972578 @default.
• W2034001674 cites W2072415754 @default.
• W2034001674 cites W2114918609 @default.
• W2034001674 cites W2124378074 @default.
• W2034001674 cites W2128701038 @default.
• W2034001674 cites W2150240082 @default.
• W2034001674 cites W2156332934 @default.
• W2034001674 cites W2156528952 @default.
• W2034001674 cites W2227845872 @default.
• W2034001674 cites W2413607318 @default.
• W2034001674 cites W1524462438 @default.
• W2034001674 doi "https://doi.org/10.1038/bjc.1997.478" @default.
• W2034001674 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2228054" @default.
• W2034001674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9328146" @default.
• W2034001674 hasPublicationYear "1997" @default.
• W2034001674 type Work @default.
• W2034001674 sameAs 2034001674 @default.
• W2034001674 citedByCount "10" @default.
• W2034001674 countsByYear W20340016742013 @default.
• W2034001674 countsByYear W20340016742014 @default.
• W2034001674 countsByYear W20340016742017 @default.
• W2034001674 crossrefType "journal-article" @default.
• W2034001674 hasAuthorship W2034001674A5002640669 @default.
• W2034001674 hasAuthorship W2034001674A5015252905 @default.
• W2034001674 hasAuthorship W2034001674A5036548349 @default.
• W2034001674 hasAuthorship W2034001674A5046807325 @default.
• W2034001674 hasAuthorship W2034001674A5048013654 @default.
• W2034001674 hasAuthorship W2034001674A5051457514 @default.
• W2034001674 hasAuthorship W2034001674A5062243111 @default.
• W2034001674 hasAuthorship W2034001674A5073877780 @default.
• W2034001674 hasAuthorship W2034001674A5074748428 @default.
• W2034001674 hasAuthorship W2034001674A5085788744 @default.
• W2034001674 hasBestOaLocation W20340016742 @default.
• W2034001674 hasConcept C109316439 @default.
• W2034001674 hasConcept C142724271 @default.
• W2034001674 hasConcept C153911025 @default.
• W2034001674 hasConcept C178790620 @default.
• W2034001674 hasConcept C185592680 @default.
• W2034001674 hasConcept C186807665 @default.
• W2034001674 hasConcept C192562407 @default.
• W2034001674 hasConcept C202751555 @default.
• W2034001674 hasConcept C203014093 @default.
• W2034001674 hasConcept C20639190 @default.
• W2034001674 hasConcept C25642318 @default.
• W2034001674 hasConcept C2776217527 @default.
• W2034001674 hasConcept C2778417259 @default.
• W2034001674 hasConcept C2779480358 @default.
• W2034001674 hasConcept C2779671804 @default.
• W2034001674 hasConcept C2781323092 @default.
• W2034001674 hasConcept C49040817 @default.
• W2034001674 hasConcept C502942594 @default.
• W2034001674 hasConcept C503630168 @default.
• W2034001674 hasConcept C55493867 @default.
• W2034001674 hasConcept C71924100 @default.
• W2034001674 hasConcept C79879829 @default.
• W2034001674 hasConcept C86803240 @default.
• W2034001674 hasConcept C98274493 @default.
• W2034001674 hasConceptScore W2034001674C109316439 @default.
• W2034001674 hasConceptScore W2034001674C142724271 @default.
• W2034001674 hasConceptScore W2034001674C153911025 @default.
• W2034001674 hasConceptScore W2034001674C178790620 @default.
• W2034001674 hasConceptScore W2034001674C185592680 @default.
• W2034001674 hasConceptScore W2034001674C186807665 @default.
• W2034001674 hasConceptScore W2034001674C192562407 @default.
• W2034001674 hasConceptScore W2034001674C202751555 @default.
• W2034001674 hasConceptScore W2034001674C203014093 @default.
• W2034001674 hasConceptScore W2034001674C20639190 @default.
• W2034001674 hasConceptScore W2034001674C25642318 @default.
• W2034001674 hasConceptScore W2034001674C2776217527 @default.
• W2034001674 hasConceptScore W2034001674C2778417259 @default.
• W2034001674 hasConceptScore W2034001674C2779480358 @default.
• W2034001674 hasConceptScore W2034001674C2779671804 @default.
• W2034001674 hasConceptScore W2034001674C2781323092 @default.
• W2034001674 hasConceptScore W2034001674C49040817 @default.
• W2034001674 hasConceptScore W2034001674C502942594 @default.

• next